David A Potter

Professor, Medicine - Hematology, Oncology, Transplant

Emaildapotter@umn.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise related to UN SDGs

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

5 Active
17 Finished

Phase 3 Study of Sacituzumab Govitecan (IMMU-132) Versus Treatment of Physician's Choice (TPC) in subjects with Hormonal Receptor-Positive (HR+) Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer (MBC) who have failed at le
Potter, D. A.
Immunomedics, Inc.
8/19/19 → 8/31/24
Project: Research project
Potentiation of Immune Checkpoint Blockade by Inhibition of Epoxyeicosatrienoic Acid Driven Tumor Respiration
Potter, D. A., Farrar, M. A., Schumacher, R. J. & Schwertfeger, K.
U.S. DEPARTMENT OF DEFENSE
3/15/19 → 3/14/22
Project: Research project
An Open Label Phase 2 Study of MLN0128 in Combination wi
Potter, D. A.
MILLENNIUM PHARMACEUTICALS, INC.
1/1/17 → 1/30/23
Project: Research project
A phase 3 open label, randomized, multicenter study of N
Potter, D. A.
NEKTAR THERAPEUTICS
11/1/16 → 11/30/22
Project: Research project
A phase 1b/2 study of safety and efficacy of MLN0128 (Du
Potter, D. A.
MILLENNIUM PHARMACEUTICALS, INC.
5/1/14 → 5/30/21
Project: Research project

33 Article
4 Comment/debate
4 Review article

Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis
Wang, H., Zhang, S., Yee, D., Basu, S., Beckwith, H. C., Potter, D. A. & Blaes, A. H., May 2021, In: Breast Cancer. 28, 3, p. 618-629 12 p.
Research output: Contribution to journal › Article › peer-review
Recent advances in neoadjuvant therapy for breast cancer
Potter, D. A., Herrera-Ponzanelli, C. A., Hinojosa, D., Castillo, R., Hernandez-Cruz, I., Arrieta, V. A., Franklin, M. J. & Yee, D., 2021, In: Faculty reviews. 10, p. 2
Research output: Contribution to journal › Review article › peer-review
Erratum to: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint (npj Breast Cancer, (2018), 4, 1, (26), 10.1038/s41523-018-0074-6)
I-SPY2 Investigators, Dec 1 2019, In: npj Breast Cancer. 5, 1, 2.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint
and I-SPY 2 Investigators, Dec 1 2018, In: npj Breast Cancer. 4, 1, 26.
Research output: Contribution to journal › Review article › peer-review

Open Access
9 Scopus citations
Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them
Guo, Z., Johnson, V., Barrera, J., Porras, M., Hinojosa, D., Hernández, I., McGarrah, P. & Potter, D. A., Sep 1 2018, In: Cancer and Metastasis Reviews. 37, 2-3, p. 409-423 15 p.
Research output: Contribution to journal › Review article › peer-review
7 Scopus citations